Qualitas Funds has announced that Univo IRB has been added to the Qualitas Funds IV portfolio.

Established in 2016, Univo IRB is an Independent Review Board (IRB) focused on serving biotech and small pharma sectors. The company specializes in the ethical review of Phase I-IV pharmaceutical, device, biologic, behavioral, and psycho-social research. It prioritizes efficiency and promptness in its operations while maintaining a strong focus on advocating for patient rights throughout its processes.

Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

GP Bullhound Fund VI leads €23 million...

by GP Bullhound

Established in 2015, the Valencia-based HR software company, Sesame, h...

Photos Stream